Adverse Events
The overall safety evaluation of NEXAVAR is based on 1286 cancer patients who
received NEXAVAR as monotherapy and 165 patients who received NEXAVAR
concurrently with chemotherapy. A total of 346 patients were exposed to NEXAVAR
monotherapy for greater than 6 months . A total of 664 RCC patients received
NEXAVAR monotherapy, of whom 215 were treated for at least 6 months. A full
presentation of safety information is provided in the Product Monograph.
Clinically significant adverse events included hypertension (17% for sorafenib vs 2% for
placebo), hemorrhage (15% sorafenib vs 8% for placebo), and cardiac ischemia /
infarction (2.9% for sorafenib vs 0.4% for placebo).
In a randomized, placebo-controlled study in locally advanced / metastatic RCC, the most
common treatment-emergent adverse events reported with sorafenib vs placebo were rash
(40% vs 16%), diarrhea (43% vs 13%), hand-foot skin reaction (30% vs 7%), fatigue
(37% vs 28%), and hypertension (17% vs 2%). Most adverse events observed with
NEXAVAR were CTCAE (National Cancer Institute Common Terminology Criteria for
Adverse Events) Grade 1 and 2. CTCAE Grade 4 drug-related adverse events were rare,
reported in 7% of patients receiving NEXAVAR compared to 6% of patients receiving
placebo.
- Forums
- ASX - By Stock
- PGL
- broker report says sell with valuation 1.50
broker report says sell with valuation 1.50, page-9
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.28M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 44.5¢ | $12.04K | 27.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 250821 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 440548 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 250821 | 0.445 |
6 | 1037333 | 0.440 |
1 | 22800 | 0.435 |
3 | 8500 | 0.350 |
1 | 2500 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 407803 | 11 |
0.460 | 100000 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
0.510 | 20000 | 1 |
Last trade - 13.46pm 19/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |